Keyphrases
B Cells
100%
Breast Cancer
100%
Basal-like
100%
Ovarian Cancer
100%
Subtype-specific
100%
MRNA-seq
100%
B Cell Receptor
66%
Tumor
50%
Ovarian Tumor
50%
Improved Prognosis
33%
Breast Tumor
33%
B Cell Response
33%
Somatic Hypermutation
33%
HER2-enriched
33%
Immune Response
16%
Progression-free Survival
16%
Adaptive Immune Response
16%
Metastasis
16%
Cell Population
16%
Breast
16%
Epitope
16%
Cancer Genome Atlas
16%
Improved Outcomes
16%
Microarray Data
16%
Survival Benefit
16%
Therapeutic Approaches
16%
Lymphocyte Infiltration
16%
Gene Segment
16%
Receptor Gene
16%
Breast Cancer Subtypes
16%
High-level Expression
16%
Improved Survival
16%
Antitumor
16%
Sequence Variants
16%
Gene Signature
16%
Immune Infiltration
16%
Immunomodulatory Therapy
16%
Patients with Breast Cancer
16%
Population Diversity
16%
Low Diversity
16%
Genomic Subtyping
16%
Immune Gene Expression
16%
Ovarian Cancer Subtypes
16%
HER2-enriched Breast Cancer
16%
Medicine and Dentistry
B Cell
100%
Breast Cancer
100%
Ovarian Cancer
100%
Messenger RNA
100%
B Lymphocyte Receptor
57%
Neoplasm
42%
Ovarian Tumor
42%
Breast Tumor
28%
Somatic Hypermutation
28%
Gene Expression Profiling
14%
Progression Free Survival
14%
Immune Response
14%
Cell Population
14%
Metastatic Carcinoma
14%
Gene Expression
14%
Epitope
14%
The Cancer Genome Atlas
14%
Receptor Gene
14%
Immunity
14%
Lymphocytic Infiltration
14%
Immune Cell Infiltration
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Ovary Cancer
100%
B Lymphocyte Receptor
100%
Messenger RNA
100%
Neoplasm
75%
Ovary Tumor
75%
Breast Tumor
50%
Malignant Neoplasm
25%
Progression Free Survival
25%
Epitope
25%
Lymphocytic Infiltration
25%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
Messenger RNA
100%
B-Cell Receptor
57%
Immunity
28%
Somatic Hypermutation
28%
Gene Expression
14%
Gene Expression Profiling
14%
Microarrays
14%
Immune Response
14%
Receptor Gene
14%
Progression Free Survival
14%
Gene Segment
14%
Genomics
14%